Your search returned 2 results.

Results
	1.	Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue. [electronic resource] by Novotny-Diermayr, Veronica Sausgruber, Nina Loh, Yung Kiang Pasha, Mohammed Khalid Jayaraman, Ramesh Hentze, Hannes Yong, Wei-Peng Goh, Boon-Cher Toh, Han-Chong Ethirajulu, Kantharaj Zhu, Joy Wood, Jeanette Marjorie Producer: 20111103 In: Molecular cancer therapeutics vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer. [electronic resource] by Novotny-Diermayr, Veronica Sangthongpitag, Kanda Hu, Chang Yong Wu, Xiaofeng Sausgruber, Nina Yeo, Pauline Greicius, Gediminas Pettersson, Sven Liang, Ai Leng Loh, Yung Kiang Bonday, Zahid Goh, Kee Chuan Hentze, Hannes Hart, Stefan Wang, Haishan Ethirajulu, Kantharaj Wood, Jeanette Marjorie Producer: 20100618 In: Molecular cancer therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search